| Vaping versus JUULing: how the extraordinary growth and marketing of JUUL transformed the US retail e-cigarette market |
98 |
| Prevalence and correlates of JUUL use among a national sample of youth and young adults |
42 |
| Global economic cost of smoking-attributable diseases |
40 |
| Heat-not-burn tobacco products: a systematic literature review |
40 |
| Heat-not-burn tobacco product use in Japan: its prevalence, predictors and perceived symptoms from exposure to secondhand heat-not-burn tobacco aerosol |
37 |
| Nicotine arms race: JUUL and the high-nicotine product market |
33 |
| Examining the relationship of vaping to smoking initiation among US youth and young adults: a reality check |
31 |
| Comparing the cancer potencies of emissions from vapourised nicotine products including e-cigarettes with those of tobacco smoke |
30 |
| Characteristics and toxicant emissions of JUUL electronic cigarettes |
30 |
| IQOS: examination of Philip Morris International's claim of reduced exposure |
28 |
| E-cigarette initiation and associated changes in smoking cessation and reduction: the Population Assessment of Tobacco and Health Study, 2013-2015 |
26 |
| Potential deaths averted in USA by replacing cigarettes with e-cigarettes |
24 |
| Awareness, experience and prevalence of heated tobacco product, IQOS, among young Korean adults |
24 |
| On the popularity of the USB flash drive-shaped electronic cigarette Juul |
23 |
| Transitions in electronic cigarette use among adults in the Population Assessment of Tobacco and Health (PATH) Study, Waves 1 and 2 (2013-2015) |
22 |
| Impact of tobacco control policies on smoking prevalence and quit ratios in 27 European Union countries from 2006 to 2014 |
22 |
| JUUL and other stealth vaporisers: hiding the habit from parents and teachers |
22 |
| Impact of the WHO FCTC over the first decade: a global evidence review prepared for the Impact Assessment Expert Group |
22 |
| Examining perceptions about IQOS heated tobacco product: consumer studies in Japan and Switzerland |
21 |
| Electronic cigarette explosion and burn injuries, US Emergency Departments 2015-2017 |
21 |
| Do electronic cigarettes increase cigarette smoking in UK adolescents? Evidence from a 12-month prospective study |
21 |
| Vascular endothelial function is impaired by aerosol from a single IQOS HeatStick to the same extent as by cigarette smoke |
21 |
| Comparing the cytotoxicity of electronic cigarette fluids, aerosols and solvents |
18 |
| Recommended core items to assess e-cigarette use in population-based surveys |
18 |
| Heated tobacco products likely appeal to adolescents and young adults |
17 |
| Relationship between trying an electronic cigarette and subsequent cigarette experimentation in Scottish adolescents: a cohort study |
17 |
| Changes in smoking cessation assistance in the European Union between 2012 and 2017: pharmacotherapy versus counselling versus e-cigarettes |
17 |
| Assessment of industry data on pulmonary and immunosuppressive effects of IQOS |
17 |
| Cytotoxic effects of heated tobacco products (HTP) on human bronchial epithelial cells |
16 |
| Dual use of electronic nicotine delivery systems (ENDS) and smoked tobacco: a qualitative analysis |
15 |
| Global burden of all-cause and cause-specific mortality due to smokeless tobacco use: systematic review and meta-analysis |
15 |
| Return of cartoon to market e-cigarette-related products |
14 |
| Negative affect, message reactance and perceived risk: how do pictorial cigarette pack warnings change quit intentions? |
13 |
| Impact of five tobacco endgame strategies on future smoking prevalence, population health and health system costs: two modelling studies to inform the tobacco endgame |
13 |
| Defending strong tobacco packaging and labelling regulations in Uruguay: transnational tobacco control network versus Philip Morris International |
12 |
| PMI's own in vivo clinical data on biomarkers of potential harm in Americans show that IQOS is not detectably different from conventional cigarettes |
12 |
| Plain packaging: legislative differences in Australia, France, the UK, New Zealand and Norway, and options for strengthening regulations |
12 |
| Awareness and use of heated tobacco products among US adults, 2016-2017 |
12 |
| iQOS: evidence of pyrolysis and release of a toxicant from plastic |
11 |
| Light and mild redux: heated tobacco products' reduced exposure claims are likely to be misunderstood as reduced risk claims |
11 |
| Tobacco control and Healthy China 2030 |
11 |
| Evaluation of California's 'Tobacco 21' law |
11 |
| Should flavours be banned in cigarettes and e-cigarettes? Evidence on adult smokers and recent quitters from a discrete choice experiment |
10 |
| Toxicant inhalation among singleton waterpipe tobacco users in natural settings |
10 |
| National and state patterns of concept-flavoured cigar sales, USA, 2012-2016 |
10 |
| Tobacco industry data on illicit tobacco trade: a systematic review of existing assessments |
10 |
| Tobacco industry strategies undermine government tax policy: evidence from commercial data |
10 |
| Educational and wealth inequalities in tobacco use among men and women in 54 low-income and middle-income countries |
9 |
| Evaluation of a complex healthcare intervention to increase smoking cessation in pregnant women: interrupted time series analysis with economic evaluation |
9 |
| Heated tobacco products: another tobacco industry global strategy to slow progress in tobacco control |
9 |
